Xenetic Biosciences EPS Diluted from Other Gain/Loss (Quarterly) Insights

Xenetic Biosciences, Inc. (XBIO)

2.32 -0.12 (-4.92%) USD | NASDAQ | Dec 15, 10:55

View EPS Diluted from Other Gain/Loss (Quarterly) for XBIO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Other Gain/Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

Start Trial

Iovance Biotherapeutics, Inc.	--
Travere Therapeutics, Inc.	--
KalVista Pharmaceuticals, Inc.	--
BeyondSpring, Inc.	--
Solid Biosciences, Inc.	--